Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EQUIFAX INCEFX · Entity 3235 | EVP, President International | February 11, 2025 | February 13, 2025 |
| JACK HENRY & ASSOCIATES INCJKHY · Entity 3466 | Director | November 17, 2025 | November 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EQUIFAX INC
Report date February 11, 2025 · Filed February 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,653 |
Last balance in matching sequence
After 2025-02-12 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2025-02-11 · Grant · Acquired 2,203 · Balance 15,886 F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Row 2 · 2025-02-11 · Tax withholding · Disposed 1,681 · Balance 14,205 F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Row 3 · 2025-02-12 · Sale · Disposed 552 · Balance 13,653 F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024. F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024.
JACK HENRY & ASSOCIATES INC
Report date November 17, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,220 |
Reported balance
After 2025-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 1,220 · Balance 1,220 F1: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof. F2: On November 17, 2025, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2026 Annual Meeting of Stockholders or (2) the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof.
F2: On November 17, 2025, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2026 Annual Meeting of Stockholders or (2) the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2025 Filed Nov 18, 2025 21:24 UTC | JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 | GrantRestricted Stock Units · Derivative | 1,220 | $0.00 | $0.00 |
DisclosureSEC source: 0000779152-25-000131 · wk-form4_1763501057.xml · derivative · entry 1 Nelson Lisa M · CIK 0001865864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,220 Underlying: Common Stock · 1,220 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof. F2 · derivative.exercise_date: On November 17, 2025, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2026 Annual Meeting of Stockholders or (2) the first anniversary of the grant date. F2 · derivative.expiration_date: On November 17, 2025, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2026 Annual Meeting of Stockholders or (2) the first anniversary of the grant date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:34 UTC | JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 | Exercise / conversionRestricted Stock Units · Derivative | 1,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000779152-25-000119 · wk-form4_1763062478.xml · derivative · entry 2 Nelson Lisa M · CIK 0001865864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,159 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof. F2 · derivative.exercise_date: On November 15, 2024, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2025 Annual Meeting of Stockholders or (2) the first anniversary of the grant date. F2 · derivative.expiration_date: On November 15, 2024, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2025 Annual Meeting of Stockholders or (2) the first anniversary of the grant date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:34 UTC | JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 | Exercise / conversionCommon Stock | 1,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000779152-25-000119 · wk-form4_1763062478.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2025 Filed Feb 13, 2025 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 552 | $248.18 | $136,995.36 |
DisclosureSEC source: 0001225208-25-001648 · doc4.xml · nonDerivative · entry 3 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,653 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024. F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 1,681 | $253.00 | $425,293.00 |
DisclosureSEC source: 0001225208-25-001648 · doc4.xml · nonDerivative · entry 2 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,205 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001648 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,886 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 6,352 | $0.00 Strike: $252.90 | $0.00 |
DisclosureSEC source: 0001225208-25-001586 · doc4.xml · derivative · entry 2 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,352 Underlying: Common Stock · 6,352 shares Expires 2035-02-10 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2026. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,978 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001586 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,683 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 551 | $260.39 | $143,474.89 |
DisclosureSEC source: 0001225208-24-010250 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,697 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 19:59 UTC | JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 | GrantRestricted Stock Units · Derivative | 1,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000779152-24-000145 · wk-form4_1732046350.xml · derivative · entry 1 Nelson Lisa M · CIK 0001865864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,159 Underlying: Common Stock · 1,159 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof. F2 · derivative.exercise_date: On November 15, 2024, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2025 Annual Meeting of Stockholders or (2) the first anniversary of the grant date F2 · derivative.expiration_date: On November 15, 2024, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2025 Annual Meeting of Stockholders or (2) the first anniversary of the grant date Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:49 UTC | JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 | Exercise / conversionRestricted Stock Units · Derivative | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0000779152-24-000124 · wk-form4_1731534566.xml · derivative · entry 2 Nelson Lisa M · CIK 0001865864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof. F2 · derivative.exercise_date: On July 23, 2024, the reporting person was granted restricted stock units, vesting in full on the the day before the Issuer's 2024 Annual Meeting of Stockholders. F2 · derivative.expiration_date: On July 23, 2024, the reporting person was granted restricted stock units, vesting in full on the the day before the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:49 UTC | JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 | Exercise / conversionCommon Stock | 365 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000779152-24-000124 · wk-form4_1731534566.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof. Read SEC document |
| July 23, 2024 Filed Jul 25, 2024 20:21 UTC | JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 | GrantRestricted Stock Units · Derivative | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0000779152-24-000058 · wk-form4_1721938882.xml · derivative · entry 1 Nelson Lisa M · CIK 0001865864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365 Underlying: Common Stock · 365 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof. F2 · derivative.exercise_date: On July 23, 2024, the reporting person was granted restricted stock units, vesting in full on the the day before the Issuer's 2024 Annual Meeting of Stockholders. F2 · derivative.expiration_date: On July 23, 2024, the reporting person was granted restricted stock units, vesting in full on the the day before the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:50 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 1,402 | $255.78 | $358,603.56 |
DisclosureSEC source: 0001225208-24-002072 · doc4.xml · nonDerivative · entry 2 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,223 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:50 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002072 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,625 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:10 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 6,452 | $0.00 Strike: $249.18 | $0.00 |
DisclosureSEC source: 0001225208-24-001936 · doc4.xml · derivative · entry 2 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,452 Underlying: Common Stock · 6,452 shares Expires 2034-02-09 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:10 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-001936 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,490 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 391 | $203.81 | $79,689.71 |
DisclosureSEC source: 0001225208-23-002663 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,447 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 7,730 | $0.00 Strike: $206.16 | $0.00 |
DisclosureSEC source: 0001225208-23-001892 · doc4.xml · derivative · entry 2 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,730 Underlying: Common Stock · 7,730 shares Expires 2033-02-10 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2024. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,426 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001892 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,838 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 40 | $160.23 | $6,409.14 |
DisclosureSEC source: 0001225208-22-011404 · doc4.xml · nonDerivative · entry 3 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,406 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $160.02 to $160.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 39 | $159.50 | $6,220.50 |
DisclosureSEC source: 0001225208-22-011404 · doc4.xml · nonDerivative · entry 2 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,446 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $159.01 to $159.895, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 21 | $158.51 | $3,328.67 |
DisclosureSEC source: 0001225208-22-011404 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,485 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $158.01 to $158.915, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:09 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 84 | $168.99 | $14,195.16 |
DisclosureSEC source: 0001225208-22-011322 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,506 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 257 | $164.82 | $42,359.10 |
DisclosureSEC source: 0001225208-22-011213 · doc4.xml · nonDerivative · entry 5 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,590 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $164.36 to $165.18, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 194 | $166.82 | $32,362.92 |
DisclosureSEC source: 0001225208-22-011213 · doc4.xml · nonDerivative · entry 4 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,847 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $166.50 to $166.98, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 112 | $165.71 | $18,559.50 |
DisclosureSEC source: 0001225208-22-011213 · doc4.xml · nonDerivative · entry 3 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,041 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $165.45 to $165.87, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 61 | $162.60 | $9,918.87 |
DisclosureSEC source: 0001225208-22-011213 · doc4.xml · nonDerivative · entry 2 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,153 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $162.59 to $163.03, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 60 | $167.61 | $10,056.60 |
DisclosureSEC source: 0001225208-22-011213 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,214 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 754 | $210.78 | $158,928.12 |
DisclosureSEC source: 0001225208-22-009173 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · EVP, President International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,266 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 754 | $212.24 | $160,028.96 |
DisclosureSEC source: 0001225208-22-003267 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · President-International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 22:34 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 5,772 | $0.00 Strike: $225.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002193 · doc4.xml · derivative · entry 2 Nelson Lisa M · CIK 0001865864 · President-International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,772 Underlying: Common Stock · 5,772 shares Expires 2032-02-11 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/11/2023. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 22:34 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002193 · doc4.xml · nonDerivative · entry 1 Nelson Lisa M · CIK 0001865864 · President-International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,754 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.